Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders
Journal article published in 2000 by
J. C. Byrd,
M. R. Grever,
J. K. Waselenko,
C. R. Willis,
K. Park,
A. Goodrich,
Lucas,
C. Shinn,
I. W. Flinn 
